Case-Fatality and Functional Outcome after Subarachnoid Hemorrhage (SAH) in INternational STRoke oUtComes sTudy (INSTRUCT)

There are few large population-based studies of outcomes after subarachnoid hemorrhage (SAH) than other stroke types. We pooled data from 13 population-based stroke incidence studies (10 studies from the INternational STRroke oUtComes sTudy (INSTRUCT) and 3 new studies; N=657). Primary outcomes were...

Full description

Saved in:
Bibliographic Details
Published inJournal of stroke and cerebrovascular diseases Vol. 31; no. 1; p. 106201
Main Authors Rehman, Sabah, Phan, Hoang T., Reeves, Mathew J., Thrift, Amanda G., Cadilhac, Dominique A., Sturm, Jonathan, Breslin, Monique, Callisaya, Michele L., Vemmos, Konstantinos, Parmar, Priya, Krishnamurthi, Rita V., Barker-Collo, Suzanne, Feigin, Valery, Chausson, Nicolas, Olindo, Stephane, Cabral, Norberto L., Carolei, Antonio, Marini, Carmine, Degan, Diana, Sacco, Simona, Correia, Manuel, Appelros, Peter, Kõrv, Janika, Vibo, Riina, Minelli, Cesar, Sposato, Luciano, Pandian, Jeyaraj Durai, Kaur, Paramdeep, Azarpazhooh, M. Reza, Morovatdar, Negar, Gall, Seana
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.01.2022
Subjects
Online AccessGet full text
ISSN1052-3057
1532-8511
1532-8511
DOI10.1016/j.jstrokecerebrovasdis.2021.106201

Cover

More Information
Summary:There are few large population-based studies of outcomes after subarachnoid hemorrhage (SAH) than other stroke types. We pooled data from 13 population-based stroke incidence studies (10 studies from the INternational STRroke oUtComes sTudy (INSTRUCT) and 3 new studies; N=657). Primary outcomes were case-fatality and functional outcome (modified Rankin scale score 3-5 [poor] vs. 0-2 [good]). Harmonized patient-level factors included age, sex, health behaviours (e.g. current smoking at baseline), comorbidities (e.g.history of hypertension), baseline stroke severity (e.g. NIHSS >7) and year of stroke. We estimated predictors of case-fatality and functional outcome using Poisson regression and generalized estimating equations using log-binomial models respectively at multiple timepoints. Case-fatality rate was 33% at 1 month, 43% at 1 year, and 47% at 5 years. Poor functional outcome was present in 27% of survivors at 1 month and 15% at 1 year. In multivariable analysis, predictors of death at 1-month were age (per decade increase MRR 1.14 [1.07-1.22]) and SAH severity (MRR 1.87 [1.50-2.33]); at 1 year were age (MRR 1.53 [1.34-1.56]), current smoking (MRR 1.82 [1.20-2.72]) and SAH severity (MRR 3.00 [2.06-4.33]) and; at 5 years were age (MRR 1.63 [1.45-1.84]), current smoking (MRR 2.29 [1.54-3.46]) and severity of SAH (MRR 2.10 [1.44-3.05]). Predictors of poor functional outcome at 1 month were age (per decade increase RR 1.32 [1.11-1.56]) and SAH severity (RR 1.85 [1.06-3.23]), and SAH severity (RR 7.09 [3.17-15.85]) at 1 year. Although age is a non-modifiable risk factor for poor outcomes after SAH, however, severity of SAH and smoking are potential targets to improve the outcomes.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1052-3057
1532-8511
1532-8511
DOI:10.1016/j.jstrokecerebrovasdis.2021.106201